Showing 1 posts of 1 posts found.
Pfizer has again slimmed down its product pipeline as the US giant looks to cut R&D spending and sharpen its …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement